The Clinical Relevance and Potential Benefit of Stem Cells and Regenerative Medicine

Are you looking for a different and advanced medical treatment? You are probably already familiar with the emerging era of stem cells and regenerative medicine, the hype of miracle cures and success stories along with warnings of fraud, potential harm and ethical critics. You can surf the web and encounter plethora of websites, hospitals, organizations, academic centers, all describing up to date thorough theoretical explanations, breakthroughs and innovations. If you are a patient who is seeking a very specific treatment, you will need to go through a lot of interesting but non relevant information for your immediate medical needs. You can learn about new genes controlling the development of different types of stem cells; a unique and rare type of stem cells found in the menstrual blood; a new technology to overcome blindness tested in mouse; multiple reasons for storing your baby’s stem cells, and many more. Some information is provided by prestigious universities and established medical centers, and other by less known small clinics and blogs.

Can this type of information help you to cope with your present medical ailment? Unfortunately, your current needs as patient or family can not be easily extracted from all this huge amount of data.

For many chronic and life threatening diseases, the advanced technologies of cell and stem cell therapy offer both experimental and more established new treatments. What patients and most people need is very relevant information addressing clinical situations and their possible novel treatments.

A unique online information source on clinics, hospitals and treatments in the emerging fields of stem cells, regenerative medicine and immunotherapy is essential. It should enable patients to select and judge clinics and treatments according to their individual condition, location and risk assessment. It should focus on patient’s needs, emphasizing clinical studies and published results for cancer and other chronic and life threatening diseases. A patient should be able to focus on his medical condition without going into details of scientific data or academic presentations. It should be patient’s focused source for innovative and mainly experimental cell therapy options, in offshore clinics as well as FDA approved clinical studies.

The first and approved clinical utilization of stem cells is bone marrow transplantation as part of the treatment for hematological malignancies. Similar procedures are intensively tested in various hospitals for treatment of autoimmune diseases. The next clinically relevant breakthrough will probably be in the regenerative treatment of cardiovascular diseases. Numerous controlled and FDA registered clinical trials are presently conducted for treating heart diseases and peripheral arterial diseases. The other categories which are presently entering into intensive clinical studies are diabetes type1, muscular distrophy, amyotropic lateral sclerosis and some neurodegenerative diseases. There are many pilot and preliminary studies for additional conditions, as well as treatments carried out in clinics all over the world, which are worth following.

A source of reliable updated and clinically focused information in the emerging fields of regenerative medicine and cell therapies is needed, especially for patients and people which are looking for the presently applicable data, and not only academic or general interest.

Source by Avi Treves

Latest articles

Related articles


Comments are closed.